JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
Year: 2014
Type: review
Abstract: The Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma proposed by the Japan Society of Hepatology was updated in June 2014 at a consensus meeting of the Liver Cancer Study Group of Japan. Three important items have been updated: the surveillance and diagnostic algorithm, the treatment algorithm, and the definition of transarterial chemoembolization (TACE) failure/refractoriness. The most important update to the diagnostic algorithm is the inclusion of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a first line surveillance/diagnostic tool. Another significant update concerns removal of the term "lipiodol" from the definition of TACE failure/refractoriness.
Source: Liver Cancer
DOI: 10.1159/000343875
Authors: Masatoshi Kudo, Osamu Matsui, Namiki Izumi, Hiroko Iijima, Masumi Kadoya, Yasuharu Imai, Takuji Okusaka, Shiro Miyayama, Kaoru Tsuchiya, Kazuomi Ueshima, Atsushi Hiraoka, Masafumi Ikeda, Sadahisa Ogasawara, Tatsuya Yamashita, Tetsuya Minami, Koichiro Yamakado, on behalf of the Liver Cancer Study Group of Japan
Institutions: Kindai University Hospital, Kindai University, Kanazawa University, Musashino Red Cross Hospital, Hyogo Medical University, Shinshu University, Ikeda Municipal Hospital, National Cancer Center Hospital, Fukui-ken Saiseikai Hospital, Ehime Prefectural Central Hospital, National Cancer Center Hospital East, Chiba University, Kanazawa University Hospital, Mie University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,590
OpenAlex ID: W1967541992